You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc. (D. Del. 2014)

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-02-27
Court District Court, D. Delaware Date Terminated 2016-02-29
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Patents 7,601,758; 7,619,004; 7,820,681; 7,906,519; 7,915,269; 7,935,731; 7,964,647; 7,964,648; 7,981,938; 8,093,296; 8,093,297; 8,093,298; 8,097,655; 8,415,395; 8,415,396; 8,440,721; 8,440,722
Link to Docket External link to docket
Small Molecule Drugs cited in Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-02-27 1 of COLCRYS®. A. United Sates Patent Number 7,619,004 (“the ‘004 Patent”), entitled “METHODS FOR CONCOMITANT…722 Patents are collectively referred to herein as the “Patents.” l6. Takeda has submitted patent information…the inventor. B. United States Patent Number 7,6()1,758 (“the ‘758 Patent”), entitled “METHODS FOR CONCOMITANT…Page|D #: 4 C. United States Patent Number 7,820,681 (“the ‘681 Patent”), entitled “METHODS FOR CONCOMITANT…the inventor. D. United States Patent Number 7,915,269 (“the ‘269 Patent”), entitled “METHODS FOR CONCOMITANT External link to document
2014-06-23 29 amp; Gout Count V U.S. Patent 7,619,004 Treatment of Gout Count V1 U.S. Patent 7,601,75 8 Treatment of… was filed in 2008, resulting in U.S. Patent No. 7,619,004. Case 1:14-cv-00268-SLR Document 29 Filed …Watson wins this patent litigation with respect to the FMF patents 1f the Orange Book patents for Watson’s…PROCEEDING This is a patent infringement lawsuit involving several Takeda patents that purport to cover…Goggin Ex. 7.) These patent applications ultimately matured into the 17 patents that Takeda seeks to External link to document
2014-02-27 3 of the Patent: 7,619,004 expires 12/3/28* Thirty Month Stay Deadline: July 31, 2016 * 7,601,758 expires… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: 1/31/14. Date of Expiration of Patent: SEE FORM.Thirty Month Stay Deadline: 7/31/2016… Civil Aetion No. SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION… 29 February 2016 1:14-cv-00268-SLR Patent None District Court, D. Delaware External link to document
2014-09-04 36 19, ex. 1 at~ 17)3 Fourteen patents- U.S. Patent Nos. 7,619,004; 7,601 ,758; 7,820,681; 7,915,269; 7,964,647…gout (the "gout patents"). (/d. at~ 15) Five patents- U.S. Patent Nos. 7,906,519; 7,935…,648 ("the '648 patent"), and 8,093,297 ("the 297 patent")- include claims directed…7,935, 731; 8,093,298; the '648 patent; and the 297 patent- include claims directed to the treatment…FMF (the "FMF patents"). (/d. at ~ 14) The '648 and '297 patents include claims directed External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.